De novo driver alterations
Typical setting: Somatic mutations or rearrangements arise in a haematopoietic progenitor.
Cooperating lesions impair differentiation and increase self-renewal.
Acute Leukaemia module
Trace clonal blast expansion through marrow failure, tissue infiltration, tumour lysis, diagnosis, and urgent subtype-directed treatment.
Clinically reviewed by Mark · NMC-registered nurse
Aetiology
Different triggers converge on the condition's central pathological process.
Typical setting: Somatic mutations or rearrangements arise in a haematopoietic progenitor.
Cooperating lesions impair differentiation and increase self-renewal.
Typical setting: Myelodysplasia or a myeloproliferative neoplasm acquires additional drivers.
Clonal evolution transforms chronic ineffective haematopoiesis into acute blast proliferation.
Typical setting: Prior cytotoxic chemotherapy or radiation damages progenitor DNA.
Selected clones with characteristic genetic abnormalities may emerge years later.
Typical setting: Down syndrome and germline DNA-repair or marrow-failure syndromes raise risk.
Constitutional genomic instability lowers the threshold for malignant transformation.
Typical setting: PML-RARA in acute promyelocytic leukaemia or BCR-ABL1 in some ALL creates a distinct biology.
The altered protein becomes both a disease driver and a treatment target.
Mechanism chain
Follow each link and use it to predict the next clinical consequence.
Self-renewal rises and normal maturation is blocked.
The malignant clone progressively occupies haematopoietic space and resources.
Keep exploring